Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC17H16N2O3 |
InChIKeyRFDVEAHRRMEOHK-UHFFFAOYSA-N |
CAS Registry2231747-03-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | GB | 01 Jul 2018 | |
Neoplasms | Preclinical | GB | 01 Jul 2018 |